Advances in lung cancer therapy-New insights and perspectives of individualization in chemotherapy
Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School
Cancer therapy has recently undergone great advances based on the development of molecular target agents and medical engineering that are involved in radiotherapy and endoscopy. Especially important has been individualized therapy based on molecular target influences in various fields, molecular diagnoses, histologic diagnoses, and modification therapies of immunosystems. In the field of lung cancer, individualized therapy based on molecular targets might be a standard. The problems in individualization seem to be the weakness of diagnostic techniques and the needs of comprehensive molecular analyses that include resistant mechanisms. We should take care of novel therapies by antimetabolic agents, unusual therapies by anti-VEGF agents, and others.
Molecular targeted therapy Individualized therapy Low invasive surgery Radiotherapy Molecular diagnosis
AJRS, 3(1): 4-8, 2014